This content is restricted to members only. Please login below.
Nirsevimab Planning for the 2024-2025 RSV Season: AIM Webinar & Sanofi Resources
Related Items
Birthing Institutions and the Vaccines for Children Program
This handout outlines how birthing institution participation in VFC can ensure equitable access to vaccines, save money, and protect newborns from RSV and hepatitis B.
HPV Vaccination Age 9 From Research to Implementation
Michelle Fiscus, MD, AIM Chief Medical Officer, presented on an HPVRT webinar on November 9, 2023.
Using Qualitative Research to Increase Vaccination Access and Uptake in Under-Immunized Communities
The “Using Qualitative Research to Increase Vaccination Access and Uptake in Under-Immunized Communities” webinar presented attendees with rapid evidence-based qualitative research methods.